Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
5.04
-0.06 (-1.27%)
At close: Jun 12, 2025, 4:00 PM
4.970
-0.070 (-1.29%)
After-hours: Jun 12, 2025, 4:04 PM EDT
Sensus Healthcare Revenue
Sensus Healthcare had revenue of $8.34M in the quarter ending March 31, 2025, a decrease of -21.75%. This brings the company's revenue in the last twelve months to $39.49M, up 24.75% year-over-year. In the year 2024, Sensus Healthcare had annual revenue of $41.81M with 71.31% growth.
Revenue (ttm)
$39.49M
Revenue Growth
+24.75%
P/S Ratio
2.11
Revenue / Employee
$731,259
Employees
54
Market Cap
82.80M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.81M | 17.40M | 71.31% |
Dec 31, 2023 | 24.41M | -20.13M | -45.20% |
Dec 31, 2022 | 44.53M | 17.49M | 64.68% |
Dec 31, 2021 | 27.04M | 17.47M | 182.36% |
Dec 31, 2020 | 9.58M | -17.69M | -64.87% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
SRTS News
- 27 days ago - Sensus Healthcare, Inc. (SRTS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Sensus Healthcare Reports First Quarter 2025 Financial Results - Business Wire
- 6 weeks ago - Sensus Healthcare Celebrates Skin Cancer Awareness Month by Promoting Awareness and Spotlighting its Patient-Friendly, Non-Invasive Treatments - Business Wire
- 6 weeks ago - Sensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15 - Business Wire
- 3 months ago - Sensus Healthcare to Participate in the 37th Annual ROTH Conference - Business Wire
- 3 months ago - Sensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual Meeting - Business Wire
- 3 months ago - Sensus Healthcare Announces Publication of Study at Tri Service Military Hospital in Taiwan Demonstrating Efficacy of SRT-100® in Preventing Keloid Recurrence - Business Wire
- 4 months ago - Sensus Healthcare Buys Back Shares - Business Wire